Results 11 to 20 of about 9,327,495 (300)

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease [PDF]

open access: goldBlood Advances, 2021
Idiopathic multicentric Castleman disease (iMCD) is a poorly-understood hematologic disorder involving cytokine-induced polyclonal lymphoproliferation, systemic inflammation, and potentially-fatal multi-organ failure.
Sheila K. Pierson   +24 more
openalex   +2 more sources

A Rare Lymphoproliferative Disease: Castleman Disease

open access: yesTurkish Journal of Hematology, 2021
Castleman disease is a rare lymphoproliferative disease also known as angiofollicular lymph node hyperplasia. It is classified as hyaline vascular and plasmacytic variants histologically but characteristics of both types can coexist.
Eren Gündüz   +3 more
doaj   +2 more sources

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease [PDF]

open access: bronzeBlood, 2017
David C. Fajgenbaum   +37 more
openalex   +2 more sources

Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease [PDF]

open access: bronzeAmerican journal of hematology/oncology, 2018
Sheila K. Pierson   +10 more
openalex   +2 more sources

Emerging role of 18F-FDG PET/CT in Castleman disease: a review [PDF]

open access: goldInsights into Imaging, 2021
Castleman disease (CD) describes a group of rare hematologic conditions involving lymphadenopathy with characteristic histopathology and a spectrum of clinical abnormalities.
Benjamin Koa   +13 more
openalex   +2 more sources

Castleman Disease [PDF]

open access: yesEar, Nose & Throat Journal, 2018
HIV-negative Castleman disease has been associated with autoimmune disease, collagen vascular disorders, pulmonary arterial hypertension, and glomerulopathy.
Cohn, Jason E, Zhou, Jing, Hu, Amanda
openaire   +5 more sources

The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman‐like lymphadenopathies: A 20‐year retrospective analysis of clinical and pathological features

open access: yesBritish Journal of Haematology, 2023
Castleman disease (CD) comprises a group of rare and heterogeneous haematological disorders, including unicentric (UCD) and multicentric (MCD) forms, the latter further subdivided into HHV8‐MCD, POEMS‐MCD and idiopathic‐MCD (iMCD).
S. Pelliccia   +20 more
semanticscholar   +1 more source

Castleman's Disease [PDF]

open access: yesMayo Clinic Proceedings, 1995
To describe the two variants of Castleman's disease--the hyaline-vascular type and the plasma-cell type--and discuss the associated histologic features.We present a case of the hyaline-vascular type and review the literature.Castleman's disease was once thought to be localized and self-limited, but in recent years, reports have described a multicentric
H, Shahidi, J L, Myers, P A, Kvale
openaire   +3 more sources

Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease

open access: yesAmerican journal of hematology/oncology, 2021
Thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly (TAFRO) syndrome is a heterogeneous entity manifesting with a constellation of symptoms described above that can occur in the context of idiopathic multicentric ...
Yoshito Nishimura   +15 more
semanticscholar   +1 more source

Castleman's disease [PDF]

open access: yesClinical Imaging, 2003
We present a case of retroperitoneal Castleman's disease of the hyaline vascular type, with unusual MR imaging findings, differing form reports to date, along with a review of the imaging findings in Castleman's disease.
Louis M, Germaine, Jeffrey H, Newhouse
openaire   +4 more sources

Home - About - Disclaimer - Privacy